138 related articles for article (PubMed ID: 31703643)
21. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
22. Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.
Vetter M; Landin J; Szczerba BM; Castro-Giner F; Gkountela S; Donato C; Krol I; Scherrer R; Balmelli C; Malinovska A; Zippelius A; Kurzeder C; Heinzelmann-Schwarz V; Weber WP; Rochlitz C; Aceto N
Breast Cancer Res; 2018 Nov; 20(1):141. PubMed ID: 30458879
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
[TBL] [Abstract][Full Text] [Related]
24. Detection of circulating tumor cells in breast cancer with a refined immunomagnetic nanoparticle enriched assay and nested-RT-PCR.
Li FR; Li Q; Zhou HX; Qi H; Deng CY
Nanomedicine; 2013 Oct; 9(7):1106-13. PubMed ID: 23506951
[TBL] [Abstract][Full Text] [Related]
25. The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform.
Chong MH; Zhao Y; Wang J; Zha XM; Liu XA; Ling LJ; Du Q; Wang S
Br J Cancer; 2012 May; 106(10):1605-10. PubMed ID: 22516945
[TBL] [Abstract][Full Text] [Related]
26. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
27. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
29. Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis.
Saloustros E; Mavroudis D
Future Oncol; 2010 Feb; 6(2):209-19. PubMed ID: 20146580
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients.
Hall CS; Karhade MG; Bowman Bauldry JB; Valad LM; Kuerer HM; DeSnyder SM; Lucci A
J Am Coll Surg; 2016 Jul; 223(1):20-9. PubMed ID: 27049782
[TBL] [Abstract][Full Text] [Related]
31. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
32. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer.
Jotsuka T; Okumura Y; Nakano S; Nitta H; Sato T; Miyachi M; Suzumura K; Yamashita J
Surgery; 2004 Apr; 135(4):419-26. PubMed ID: 15041966
[TBL] [Abstract][Full Text] [Related]
33. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
[TBL] [Abstract][Full Text] [Related]
34. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
36. [Prediction value for dynamic changes of circulating tumor cell in therapeutic response and prognosis of Chinese metastatic breast cancer patients].
Bian L; Liu Y; Wang T; Zhang S; Shao Z; Tong Z; Song E; Wang X; Liao N; Jiang Z
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(4):265-8. PubMed ID: 24731491
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer.
Sato N; Hayashi N; Imamura Y; Tanaka Y; Kinoshita K; Kurashige J; Saito S; Karashima R; Hirashima K; Nagai Y; Miyamoto Y; Iwatsuki M; Baba Y; Watanabe M; Baba H
Ann Surg Oncol; 2012 Jun; 19(6):2060-5. PubMed ID: 21732137
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study.
Duan X; Zhu Y; Cui Y; Yang Z; Zhou S; Han Y; Yu D; Xiao N; Cao X; Li Y; Liu S; Wang Z; Zhang W; Feng L; Zhang K; Shou J; Liu Z; Xu S
Thorac Cancer; 2019 Feb; 10(2):163-169. PubMed ID: 30511800
[TBL] [Abstract][Full Text] [Related]
39. Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancer.
Georgoulias V; Apostolaki S; Bozionelou V; Politaki E; Perraki M; Georgoulia N; Kalbakis K; Kotsakis A; Xyrafas A; Agelaki S; Mavroudis D
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1217-25. PubMed ID: 25344760
[TBL] [Abstract][Full Text] [Related]
40. [The comparative study of endoscope versus open surgery on nipple sparing mastectomy with immediate reconstruction using prosthesis implantation].
Zhang Y; Zhong L; Liu J; Liu HX; Chen L; Zhang Y; Fan LJ; Jiang J
Zhonghua Wai Ke Za Zhi; 2019 Oct; 57(10):51-56. PubMed ID: 31510733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
